$805.0 Million
Alnylam Pharmaceuticals, Inc.
Follow-On Offering
Co-Manager
$130.8 Million
CRISPR Therapeutics AG
Follow-On Offering
Active Bookrunner
$258.8 Million
Array BioPharma Inc.
Follow-On Offering
Passive Bookrunner
$88.7 Million
Kadmon Holdings, LLC
Follow-On Offering
Active Bookrunner
$350.0 Million
Pacira BioSciences, Inc.
Convertible Offering
Active Bookrunner
$200.0 Million
Gossamer Bio
Convertible Offering
Active Bookrunner
$550.0 Million
BridgeBio Pharma, Inc.
Convertible Offering
Passive Bookrunner
$250.0 Million
Revance Therapeutics, Inc.
Convertible Offering
Co-Manager
$150.0 Million
PDL BioPharma, Inc.
Convertible Offering
Financial Advisor
$963.5 Million
Horizon Therapeutics Public Limited Company
Follow-On Offering
Passive Bookrunner
Subscribe to Biopharma

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.